You are watching a 25-second preview
Log in to keep watching


Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

Benefits of the ForeseeHome™ AMD Monitoring Program

Michael J. Elman, MD, of the Elman Retina Group in Baltimore, Maryland, explains the evolution of AMD management and breakthroughs in the past 20 years. Dr. Elman notes that the ForeseeHome® device represents a breakthrough in the detection of early CNV for contributing to better outcomes.

Indication for Use:

The ForeseeHome is intended for use in the detection and characterization of central and paracentral metamorphopsia (visual distortion) in patients with age-related macular degeneration, as an aid in monitoring the progression of disease factors causing metamorphopsia including but not limited to choroidal neovascularization (CNV). It is intended to be used at home for patients with stable fixation.

ForeseeHome is available by prescription only, and does not replace regularly scheduled eye exams.